Achilles Therapeutics Statistics
Total Valuation
FRA:WXF has a market cap or net worth of EUR 1.69 billion.
Market Cap | 1.69B |
Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, July 24, 2025.
Earnings Date | Jul 24, 2025 |
Ex-Dividend Date | May 8, 2025 |
Share Statistics
Current Share Class | 63.00M |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.92% |
Shares Change (QoQ) | -1.51% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 43.77M |
Valuation Ratios
The trailing PE ratio is 13.86 and the forward PE ratio is 19.13.
PE Ratio | 13.86 |
Forward PE | 19.13 |
PS Ratio | 1.61 |
PB Ratio | 0.89 |
P/TBV Ratio | 1.03 |
P/FCF Ratio | 4.89 |
P/OCF Ratio | 4.85 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | 6.02 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.98%.
Return on Equity (ROE) | 6.98% |
Return on Assets (ROA) | 0.99% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 289,254 |
Profits Per Employee | 33,629 |
Employee Count | 3,646 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:WXF has paid 34.50 million in taxes.
Income Tax | 34.50M |
Effective Tax Rate | 20.92% |
Stock Price Statistics
The stock price has decreased by -5.76% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -5.76% |
50-Day Moving Average | 25.98 |
200-Day Moving Average | 27.56 |
Relative Strength Index (RSI) | 62.22 |
Average Volume (20 Days) | 114 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.60 |
Income Statement
In the last 12 months, FRA:WXF had revenue of EUR 1.05 billion and earned 122.11 million in profits. Earnings per share was 1.89.
Revenue | 1.05B |
Gross Profit | 1.05B |
Operating Income | 164.96M |
Pretax Income | 164.96M |
Net Income | 122.11M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | 1.89 |
Balance Sheet
The company has 1.54 billion in cash and 2.08 billion in debt, giving a net cash position of -538.20 million.
Cash & Cash Equivalents | 1.54B |
Total Debt | 2.08B |
Net Cash | -538.20M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.90B |
Book Value Per Share | 29.72 |
Working Capital | -7.10B |
Cash Flow
In the last 12 months, operating cash flow was 348.80 million and capital expenditures -2.98 million, giving a free cash flow of 345.82 million.
Operating Cash Flow | 348.80M |
Capital Expenditures | -2.98M |
Free Cash Flow | 345.82M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | 15.71% |
Pretax Margin | 15.71% |
Profit Margin | 11.63% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | 32.93% |
Dividends & Yields
This stock pays an annual dividend of 0.64, which amounts to a dividend yield of 2.46%.
Dividend Per Share | 0.64 |
Dividend Yield | 2.46% |
Dividend Growth (YoY) | 5.50% |
Years of Dividend Growth | 8 |
Payout Ratio | 31.56% |
Buyback Yield | 0.92% |
Shareholder Yield | 3.38% |
Earnings Yield | 7.22% |
FCF Yield | 20.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |